<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04692714</url>
  </required_header>
  <id_info>
    <org_study_id>69HCL20_0872</org_study_id>
    <nct_id>NCT04692714</nct_id>
  </id_info>
  <brief_title>Evaluation of Two Surgical Strategies for Robotic Implantation of Total Knee Prostheses (Stryker), Cemented Versus Uncemented</brief_title>
  <acronym>MAKO CIMENT</acronym>
  <official_title>Evaluation of Two Surgical Strategies for Robotic Implantation of Total Knee Prostheses (Stryker), Cemented Versus Uncemented. Prospective, Randomized, Single-center, Multisite Non-inferiority Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Stryker Nordic</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Total knee replacement surgery (TKA) is a treatment for advanced tibial-femoral&#xD;
      osteoarthritis. This intervention is justified in case of significant discomfort and failure&#xD;
      of medical treatment. It aims to replace the native internal and external femoro-tibial&#xD;
      joints with a joint between a femoral implant and a tibial implant.&#xD;
&#xD;
      Implants can be cemented or cementless. The longevity of these implants depends among other&#xD;
      things on the quality of the bone fixation of the implants. It is therefore essential that&#xD;
      this fixation be evaluated. The advantages of an uncemented TKA are the preservation of bone&#xD;
      stock, the absence of wear by cement debris and prolonged fixation thanks to&#xD;
      osseointegration. These characteristics are all the more interesting in a young population.&#xD;
&#xD;
      Numerous studies have been carried out on the survival of TKA with and without cement. The&#xD;
      results found are not unanimous and mainly concern the survival of the implants and the&#xD;
      presence of radiological signs of loosening. In addition, no study has evaluated the results&#xD;
      of TKA with or without cement implanted using robotic assistance. The precision provided by&#xD;
      the robotic system could improve the results of these uncemented implants.&#xD;
&#xD;
      Very few studies are interested in the functional results according to the cementation or not&#xD;
      of TKA. And most of these studies do not have a high level of methodological evidence.&#xD;
&#xD;
      We would like to prospectively evaluate the functional results, survival, as well as the rate&#xD;
      of radiological border after TKA with or without cement posed with robotic assistance, in the&#xD;
      short and medium term.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 1, 2021</start_date>
  <completion_date type="Anticipated">August 1, 2028</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in International Knee Society (IKS) function score at 12 Months</measure>
    <time_frame>Baseline and 12 months</time_frame>
    <description>The knee function will be evaluated using the delta of the IKS function score between baseline (before surgery) and 1 year after total knee arthroplasty, and compared between the 2 arms.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in IKS objective score at 12 Months</measure>
    <time_frame>Baseline and 12 months</time_frame>
    <description>The knee function will be evaluated using the delta of the IKS objective score between baseline (before surgery) and 1 year after total knee arthroplasty, and compared between the 2 arms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in IKS function score at 60 Months</measure>
    <time_frame>Baseline and 60 months</time_frame>
    <description>The knee function will be evaluated using the delta of the IKS function score between baseline (before surgery) and 5 years after total knee arthroplasty.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in IKS objective score at 60 Months</measure>
    <time_frame>Baseline and 60 months</time_frame>
    <description>The knee function will be evaluated using the delta of the IKS objective score between baseline (before surgery) and 5 years after total knee arthroplasty.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Forgotten joint score at 12 Months</measure>
    <time_frame>12 months</time_frame>
    <description>Patient prosthesis acceptability will be evaluated thanks to the forgotten joint score 12 months after total knee arthroplasty</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Forgotten joint score at 60 Months</measure>
    <time_frame>60 months</time_frame>
    <description>Patient prosthesis acceptability will be evaluated thanks to the forgotten joint score 60 months after total knee arthroplasty</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence of progressive radiological border at 12 Months</measure>
    <time_frame>12 months</time_frame>
    <description>Progressive radiological border will be judged significant if it is at least 2 mm long at the interface between the implant (or cement) and the bone, or if it progresses in comparison to immediate post-surgical time.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Unsealing free survival at 60 months</measure>
    <time_frame>60 months</time_frame>
    <description>Unsealing free survival of knee prosthesis 60 months after total knee arthroplasty</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Total Knee Arthroplasty</condition>
  <arm_group>
    <arm_group_label>Experimental knee prosthesis implantation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients included in this arm will have a total knee arthroplasty using a Triathlon prosthesis by STRYKER implemented without additional cement using the MAKO robot</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional knee prosthesis implantation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients included in this arm will have a total knee arthroplasty using a Triathlon prosthesis by STRYKER implemented with additional cement using the MAKO robot</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Knee prosthesis implementation with additional cement</intervention_name>
    <description>During surgery, a TRIATHLON prosthesis will be implemented with the MAKO robot with additional cement.</description>
    <arm_group_label>Conventional knee prosthesis implantation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Knee prosthesis implementation without additional cement</intervention_name>
    <description>During surgery, a TRIATHLON prosthesis will be implemented with the MAKO robot without additional cement.</description>
    <arm_group_label>Experimental knee prosthesis implantation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosis of internal, external or global femorotibial knee osteoarthritis&#xD;
&#xD;
          -  Indication for first-line total knee arthroplasty&#xD;
&#xD;
          -  having given informed consent&#xD;
&#xD;
          -  Affiliated with a social security scheme&#xD;
&#xD;
          -  Patient being able to understand the objectives of the study and willing to comply&#xD;
             with postoperative instructions.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient with rheumatoid arthritis&#xD;
&#xD;
          -  Preoperative flexion less than 90 °&#xD;
&#xD;
          -  Prosthesis associated with an osteotomy&#xD;
&#xD;
          -  History of surgery on the operated knee, except arthroscopy&#xD;
&#xD;
          -  Poor bone quality assessed by the surgeon&#xD;
&#xD;
          -  Knee deformation greater than 10 ° preoperatively (HKA)&#xD;
&#xD;
          -  Pregnant or breastfeeding Women&#xD;
&#xD;
          -  Persons deprived of their liberty by a judicial or administrative decision, persons&#xD;
             under psychiatric care, persons admitted to a health or social institution for&#xD;
             purposes other than research&#xD;
&#xD;
          -  Adults subject to a legal protection measure&#xD;
&#xD;
          -  Patient already participating to another clinical trial that might jeopardize the&#xD;
             current trial&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sébastien LUSTIG, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospices Civils de Lyon</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sébastien LUSTIG, Professor</last_name>
    <phone>33 (0) 4 26 10 92 98</phone>
    <email>sebastien.lustig@chu-lyon.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Julien BERTHILLER</last_name>
    <phone>33 (0) 4 72 11 80 67</phone>
    <email>julien.berthiller@chu-lyon.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of orthopedic surgery, Hopital Nord Croix-Rousse- Hospices Civils de Lyon</name>
      <address>
        <city>Lyon</city>
        <zip>69004</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Sébastien LUSTIG, Professor</last_name>
      <phone>33 (0) 4 26 10 92 98</phone>
      <email>sebastien.lustig@chu-lyon.fr</email>
    </contact>
    <contact_backup>
      <last_name>Julien BERTHILLER</last_name>
      <phone>33 (0) 4 72 11 80 67</phone>
      <email>julien.berthiller@chu-lyon.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Sébastien LUSTIG, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chirurgie Orthopédique et Traumatologique Centre Hospitalier Lyon Sud, Hospices Civils de Lyon</name>
      <address>
        <city>Lyon</city>
        <zip>69495</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Anthony VISTE, MD, PhD</last_name>
      <phone>+33 (0)4 78 86 37 38</phone>
      <email>anthony.viste@chu-lyon.fr</email>
    </contact>
    <investigator>
      <last_name>Anthony VISTE, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <link>
    <url>http://www.orthopedie-lyon-croix-rousse.fr/equipe-chirurgien-orthopediste-lyon-69.html</url>
    <description>Related Info</description>
  </link>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 30, 2020</study_first_submitted>
  <study_first_submitted_qc>December 30, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 5, 2021</study_first_posted>
  <last_update_submitted>December 30, 2020</last_update_submitted>
  <last_update_submitted_qc>December 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>total knee arthroplasty</keyword>
  <keyword>prosthesis</keyword>
  <keyword>cement</keyword>
  <keyword>MAKO</keyword>
  <keyword>IKS score</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

